Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 56Neoplasms 27Prostatic Neoplasms 18Lung Neoplasms 17Head and Neck Neoplasms 14Motor Activity 12Colorectal Neoplasms 12Gastrointestinal Neoplasms 9Ovarian Neoplasms 7Neoplasm Metastasis 7Endometrial Neoplasms 7Anxiety Disorders 7Lymphoma 6Carcinoma, Non-Small-Cell Lung 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Pancreatic Neoplasms 5Pain 5Colonic Neoplasms 5Carcinoma, Renal Cell 5Smoking Cessation 4Sarcoma 4Recurrence 4Multiple Myeloma 4Melanoma 4Hematologic Neoplasms 4Fatigue 4Esophageal Neoplasms 4Depression 4Tobacco Use Cessation 3

Interventions

Genetic Counseling 2Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Interviews as Topic 1Health Promotion 1Genetic Testing 1Educational Status 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplastic Syndromes, Hereditary × Surveys and Questionnaires × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡